New Study Shows Diadem’s AlzoSure Alzheimer’s Blood Test Can Predict Disease Years Before Diagnosis

Results from a clinical validation study show that Diadem’s AlzoSure, a blood-based biomarker test, accurately predicts progression to Alzheimer’s disease (AD) up to six years prior to diagnosis. The data from the retrospective longitudinal study has been made available in a medRxiv preprint before its submission to the Journal of Neuroscience.